Remote programming and app-based hearing tests for kids and young adults with cochlear implants
Official title: Pediatric Cochlear Implant Remote Programming and Assessment
Run by Nationwide Children's Hospital · NCT07035873 · Data updated 2026-11-12
This will test whether remote programming and an iOS app for speech tests work well for teens and young adults (ages 13–20) who use Advanced Bionics cochlear implants.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 20 Years |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Nationwide Children's Hospital Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | January 15, 2025 |
| Main results expected | January 15, 2027 |
| Study ends | March 31, 2027 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT07035873 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are ages 13–20 with at least one Advanced Bionics cochlear implant, ≥6 months post-implant listening experience, ≥2 weeks with a Marvel processor, ≥40% correct on standard speech-in-quiet tests for the study ear, and willingness/ability to use an iOS device for remote sessions.
✕Probably not a fit
Patients under 13, those with speech perception <40% on standard measures, those with cognitive or language impairments that prevent reliable remote testing, or those without an Advanced Bionics device are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective interventional protocol uses a mobile iOS application to deliver remote cochlear implant programming sessions and self-administered speech perception tests in participants aged 13–20. Participants must have at least one Advanced Bionics implant, a minimum of six months post-implant listening experience, at least two weeks with the Marvel external processor, and ≥40% correct on standard speech-in-quiet measures for the tested ear. The study measures clinical outcomes, end-user satisfaction with remote programming, and the long-term reproducibility of digital audio streaming (DAS) speech-perception measures over repeated testing. Sessions are coordinated through Nationwide Children's Hospital with collaboration from Advanced Bionics, and data will be compared to standard-of-care benchmarks to identify learning effects over time.
Why it matters
Potential benefit: If successful, this approach could let eligible young cochlear implant users receive convenient remote tuning and monitoring, reducing clinic visits and improving access to follow-up care.
How similar studies have gone: Prior work has shown remote programming and app-based speech tests can be feasible and produce replicable within-session results, but long-term reproducibility and potential learning effects across repeated tests are less well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cochlear implantation with an Advanced Bionics cochlear implant in at least one ear. * At least 6 months post-implantation listening experience and at least 2 weeks of listening experience with Marvel cochlear implant external processor. * Speech perception performance of at least 40% correct on standard of care speech perception measures in quiet for the ear to be used in the study * Ages 13 years to 20 years, inclusive * Ability and willingness to participate in remote programming sessions and self-administered assessment measures Exclusion Criteria: * Children under the age of 13 * Speech perception performance \< 40% on SOC speech perception measures * Cognitive or language deficits that preclude ability and willingness to participate in remote programming sessions and self-administered assessment measures, as identified by eMR diagnoses and the participant's primary clinical audiologist judgement.
Where it's running
-
Nationwide Children's Hospital
Columbus, Ohio, United States Recruiting
Study contacts
- Principal investigator: Ursula M Findlen, PhD — Nationwide Children's Hospital
- Study coordinator: Ursula M Findlen, PhD
- Email: ursula.findlen@nationwidechildrens.org
- Phone: 614-722-6526
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transauricular Neurostimulation for Abdominal Pain in Teens
We are testing a head- and ear‑based device to see if it helps teens with abdominal pain from gut-brain disorders.
-
MedMemos: helping families stick to medications after pediatric stem cell transplant
MedMemos tests a caregiver-focused program to help families of children who had a bone marrow transplant take medications more consistently.
-
Light therapy for children in the pediatric ICU
This project will try daily bedside light therapy for children aged 4–17 in the pediatric ICU to see how easy it is to deliver and whether patients, families, and staff tolerate it.
-
Food is Medicine program to boost family heart health
The trial tests whether providing healthy food access plus personalized digital tools and coaching can improve heart health for families with a parent on Medicaid and a 6–11 year old child.
-
AI-based personalized health and self-care support for caregivers of children
This pilot will test whether the DAPHNE chatbot helps caregivers of children with unmet social needs connect to community resources, stay engaged, and fit into primary care workflows over six months.
-
Caregiver questionnaire on firearm ownership and safety
We will ask parents and legal guardians of children having surgery at Nationwide Children's Hospital about firearm ownership, storage, access, and safety education to see if common safety practices are followed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.